Heritage Cannabis Holdings Corp
Change company Symbol lookup
Select an option...
HERTF Heritage Cannabis Holdings Corp
AMD Advanced Micro Devices Inc
SMG Scotts Miracle-Gro Co
IPOF Social Capital Hedosophia Holdings Corp VI
VHC VirnetX Holding Corp
BGS B&G Foods Inc
PLFLF PlantFuel Life Inc
VINO Gaucho Group Holdings Inc
NKLA Nikola Corp

Health Care : Pharmaceuticals | Small Cap Blend
Based in Canada
Company profile

Heritage Cannabis Holdings Corp. is a Canada-based vertically integrated cannabis company. The Company focuses on extraction and the creation of extract and extract-derivative products and brands for adult use and cannabis-based medical solutions. It has a portfolio of cannabis products under the brands Purefarma, Pura Vida, Really Awesome Dope (RAD), Premium 5, feelgood., ArthroCBD and CB4. In Canada, the Company operates through its wholly owned subsidiaries Voyage Cannabis Corp. (Voyage) and CannaCure Corporation (CannaCure). In the United States, the Company operates primarily through its wholly owned subsidiary, Opticann Inc. (Opticann), a Colorado-based oral and topical cannabinoid company, which has the rights to sell non-psychoactive cannabinoids Cannabidiol (CBD) and Cannabigerol (CBG), products made with the VESIsorb drug delivery system. It operates two manufacturing facilities in Canada and offers products to both the medical and recreational legal cannabis markets.

Closing Price
Day's Change
0.00 (0.00%)
B/A Size
Day's High
Day's Low

10-day average volume:

Heritage Cannabis Announces Sale of Interest in Stanley Park Digital Ltd.

9:38 am ET March 30, 2022 (BusinessWire) Print

Heritage Cannabis Holdings Corp. (the "Company") (CSE: CANN) (OTCQX: HERTF) today announced it has sold its interest in Stanley Park Digital Ltd. ("SPD"), a technology consulting company that focusses on all aspects of Blockchain technology, based in Vancouver, BC, for total cash proceeds of approximately CDN$608,649.

Heritage initially signed a Letter of Intent to acquire 20% shares in SPD in January 2018, and subsequently finalized and completed its investment for an aggregate purchase price of CDN$340,000, representing an 18% interest in SPD in April 2020. The sale of the investment is in-line with the Company's focus on its core strengths, namely growing its recreational business and leveraging its strengths in medical channels.

Proceeds from the sale paid to Heritage were in two tranches, the first amount of CDN$444,489 has been received and the remaining CDN$164,160 is anticipated to take place in 180 days' time.

Additionally, further to the Company's press release on February 28, 2022 relating to the delay in the Company filing its 2021 annual financial statements and management's discussion and analysis (the "2021 Filings"), the Company continues to work diligently with its auditors to have the 2021 Filings completed. In addition, the Company is also in the process of completing its Q1 2022 financial statements and management's discussion and analysis and expects to file its Q1 2022 results shortly after the 2021 Filings are made.

About Heritage

Heritage Cannabis is a leading cannabis company offering innovative products to both the medical and recreational legal cannabis markets in Canada and the U.S., operating under two licensed manufacturing facilities in Canada. The company has an extensive portfolio of high-quality cannabis products under the brands Purefarma, Pura Vida, RAD, Premium 5, feelgood., the CB4 suite of medical products in Canada and ArthroCBD in the U.S.

The Canadian Securities Exchange has neither approved nor disapproved the contents of this news release.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220330005589/en/

SOURCE: Heritage Cannabis Holdings Corp.

For further information:
Kelly Castledine, Email: kcastledine@heritagecann.com, Phone: 647-660-2560
comtex tracking


Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.